These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3040658)

  • 1. Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells.
    Abruzzo GK; Fromtling RA; Turnbull TA; Giltinan DM
    J Antimicrob Chemother; 1987 Jul; 20(1):61-8. PubMed ID: 3040658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of six antifungal agents on the chemiluminescence response of mouse spleen cells.
    Abruzzo GK; Giltinan DM; Capizzi TP; Fromtling RA
    Antimicrob Agents Chemother; 1986 Apr; 29(4):602-7. PubMed ID: 3707108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes.
    Back DJ; Tjia JF
    Br J Clin Pharmacol; 1991 Nov; 32(5):624-6. PubMed ID: 1659439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azoles, allylamines and drug metabolism.
    Back DJ; Tjia JF; Abel SM
    Br J Dermatol; 1992 Feb; 126 Suppl 39():14-8. PubMed ID: 1311943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new generation of antifungal drugs.
    Stevens DA
    Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):732-5. PubMed ID: 2850912
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and analysis considerations in evaluating the chemiluminescence response of mouse spleen cells.
    Giltinan DM; Capizzi TP; Abruzzo GK; Fromtling RA
    J Clin Microbiol; 1986 Mar; 23(3):531-5. PubMed ID: 3958145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
    Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.
    Carrillo-Muñoz AJ; Guglietta A; Palacín C; Casals J; del Valle O; Guardià C; Rodríguez V; Quindós G
    Chemotherapy; 2004 Dec; 50(6):308-13. PubMed ID: 15608448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
    Bhatia VK; Sharma PC
    Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole, but not terbinafine, enhances the effects of triazolam by inhibiting its metabolism.
    Varhe A; Olkkola KT; Neuvonen PJ
    Br J Clin Pharmacol; 1996 Apr; 41(4):319-23. PubMed ID: 8730978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case Report of Penile Infection Caused by Fluconazole- and Terbinafine-Resistant Candida albicans.
    Hu Y; Hu Y; Lu Y; Huang S; Liu K; Han X; Mao Z; Wu Z; Zhou X
    Mycopathologia; 2017 Apr; 182(3-4):397-402. PubMed ID: 27659805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro and in vivo structure-activity relationships of novel antifungal triazoles for dermatology.
    Meerpoel L; Backx LJ; Van der Veken LJ; Heeres J; Corens D; De Groot A; Odds FC; Van Gerven F; Woestenborghs FA; Van Breda A; Oris M; van Dorsselaer P; Willemsens GH; Vermuyten KJ; Marichal PJ; Vanden Bossche HF; Ausma J; Borgers M
    J Med Chem; 2005 Mar; 48(6):2184-93. PubMed ID: 15771461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
    Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
    J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP).
    Gupta A; Unadkat JD; Mao Q
    J Pharm Sci; 2007 Dec; 96(12):3226-35. PubMed ID: 17518356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay.
    Koc AN; Silici S; Ayangil D; Ferahbaş A; Cankaya S
    Mycoses; 2005 May; 48(3):205-10. PubMed ID: 15842339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
    Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
    Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New oral treatments for dermatophytosis.
    Hay RJ
    Ann N Y Acad Sci; 1988; 544():580-5. PubMed ID: 2850758
    [No Abstract]   [Full Text] [Related]  

  • 19. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
    Gilgado F; Serena C; Cano J; Gené J; Guarro J
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4211-3. PubMed ID: 17015631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro activity of ketoconazole, itraconazole and terbinafine against Malassezia strains isolated from neonates].
    Sancak B; Ayhan M; Karaduman A; Arikan S
    Mikrobiyol Bul; 2005 Jul; 39(3):301-8. PubMed ID: 16358489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.